163 related articles for article (PubMed ID: 17213349)
1. Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy.
Redmond M; Quinn J; Murphy P; Patchett S; Leader M
J Clin Pathol; 2007 Jan; 60(1):80-1. PubMed ID: 17213349
[TBL] [Abstract][Full Text] [Related]
2. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
[No Abstract] [Full Text] [Related]
3. Mucormycosis in a Crohn's disease patient treated with infliximab.
Wall GC; Leman BI
Digestion; 2009; 80(3):182-4. PubMed ID: 19776582
[TBL] [Abstract][Full Text] [Related]
4. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
[TBL] [Abstract][Full Text] [Related]
5. Granular cell tumour in a patient with Crohn's disease treated with infliximab: coincidence or causal relationship?
Papamichael K; Archavlis E; Lariou C; Tsigka A; Mantzaris GJ
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):857-9. PubMed ID: 22475791
[TBL] [Abstract][Full Text] [Related]
6. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
[TBL] [Abstract][Full Text] [Related]
7. EBV-associated plasmablastic lymphoma in a patient with Crohn's disease after adalimumab treatment.
Liu L; Charabaty A; Ozdemirli M
J Crohns Colitis; 2013 Apr; 7(3):e118-9. PubMed ID: 22902264
[No Abstract] [Full Text] [Related]
8. How to improve the safety of biologic therapy in Crohn's disease.
Ferkolj I
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():67-70. PubMed ID: 20388947
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease.
Tichy M; Tichy M; Kopova R; Sternbersky J; Ditrichova D
J Dermatolog Treat; 2012 Jun; 23(3):208-11. PubMed ID: 21254868
[TBL] [Abstract][Full Text] [Related]
10. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
Baert F; Noman M; Vermeire S; Van Assche G; D' Haens G; Carbonez A; Rutgeerts P
N Engl J Med; 2003 Feb; 348(7):601-8. PubMed ID: 12584368
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated lymphoma in Crohn's disease.
Losco A; Gianelli U; Cassani B; Baldini L; Conte D; Basilisco G
Inflamm Bowel Dis; 2004 Jul; 10(4):425-9. PubMed ID: 15475752
[TBL] [Abstract][Full Text] [Related]
12. Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNF therapy.
Rampton DS
Gut; 2005 Oct; 54(10):1360-2. PubMed ID: 16113045
[No Abstract] [Full Text] [Related]
13. Cutaneous nevi pigmentosus during infliximab therapy in a patient with Crohn's disease: fallacy or coincidence?
Katsanos KH; Christodoulou DK; Zioga A; Tsianos EV
Inflamm Bowel Dis; 2003 Jul; 9(4):279. PubMed ID: 12902853
[No Abstract] [Full Text] [Related]
14. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
[TBL] [Abstract][Full Text] [Related]
16. Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?
Fiocchi C
N Engl J Med; 2004 Feb; 350(9):934-6. PubMed ID: 14985492
[No Abstract] [Full Text] [Related]
17. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
[No Abstract] [Full Text] [Related]
18. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
[No Abstract] [Full Text] [Related]
19. Balancing the risks and benefits of prolonged use of infliximab.
Schölmerich J
Gut; 2009 Apr; 58(4):477-8. PubMed ID: 19299379
[No Abstract] [Full Text] [Related]
20. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
Minnee RC; Stokkers P; Riemens SC; Hommes DW
Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
